Showing results (681-690 of 4,512) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|June 30, 2021
High PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor in urothelial carcinomaQiaofeng Zhong, Jianzhong Shou, Jianming Ying, et al.
Future Oncology (London, England)|July 2, 2021
Patient engagement in melanoma research: from bench to bedsideAnn Tivey, Prerana Huddar, Rohan Shotton, et al.
Future Oncology (London, England)|April 7, 2020
ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1Grzegorz S Nowakowski, Jun Zhu, Qingyuan Zhang, et al.
Future Oncology (London, England)|April 8, 2020
Molecular avenues in targeted doxorubicin cancer therapySayantani Roychoudhury, Ajay Kumar, Devyani Bhatkar, et al.
Future Oncology (London, England)|April 8, 2020
Linkage disequilibrium and haplotype analysis of Src and Yes1 genes in thyroid cancerAsif Nisar, Ishrat Mahjabeen, Azhar Mehmood, et al.
Future Oncology (London, England)|January 3, 2020
Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC‡ 04-2017)Alain Vergnenegre, Isabelle Monnet, Acya Bizieux, et al.
Future Oncology (London, England)|April 4, 2020
LncRNAs adjacent to pepsinogen C in gastric diseases and diagnostic efficiencies of joint detection in gastric diseasesWen-Jing Liu, Zhi Lv, Jing-Wei Liu, et al.
Future Oncology (London, England)|December 4, 2019
Patient-generated subjective global assessment versus nutritional risk screening 2002 for gastric cancer in Chinese patientsDong Yang, Zhichao Zheng, Yan Zhao, et al.
Future Oncology (London, England)|December 5, 2019
High SLC17A9 expression correlates with poor survival in gastric carcinomaJunqing Li, Taiqiang Su, Liang Yang, et al.
Future Oncology (London, England)|December 6, 2019
Economic burden of illness associated with localized prostate cancer in the United StatesGary Gustavsen, Laura Gullet, Doria Cole, et al.
Pageof 452